Featured Research

from universities, journals, and other organizations

Computational method predicts new uses for existing medicines; Match-making program uses gene expression patterns

Date:
August 18, 2011
Source:
NIH/National Institute of General Medical Sciences
Summary:
Scientists used computers and publicly available genomic information to predict new uses for existing medicines. The approach could save time and money compared to traditional drug discovery methods. Among the study's surprise findings: an anti-ulcer medicine that slowed the growth of lung cancer, and an anticonvulsant that might alleviate inflammatory bowel diseases.

The researchers found that an anti-ulcer medicine might treat lung cancer and an anticonvulsant might alleviate inflammatory bowel diseases,
Credit: Copyright Marina Sirota

For the first time ever, scientists are using computers and genomic information to predict new uses for existing medicines.

A National Institutes of Health-funded computational study analyzed genomic and drug data to predict new uses for medicines that are already on the market. A team led by Atul J. Butte, M.D., Ph.D., of Stanford University, Palo Alto, Calif., reports its results in two articles in the Aug. 17 online issue of Science Translational Medicine.

"Bringing a new drug to market typically takes about $1 billion, and many years of research and development," said Rochelle M. Long, Ph.D., who directs the NIH Pharmacogenomics Research Network. "If we can find ways to repurpose drugs that are already approved, we could improve treatments and save both time and money."

The scientists drew their data from the NIH National Center for Biotechnology Information Gene Expression Omnibus, a publicly available database that contains the results of thousands of genomic studies on a wide range of topics, submitted by researchers across the globe. The resource catalogs changes in gene activity under various conditions, such as in diseased tissues or in response to medications.

Butte's group focused on 100 diseases and 164 drugs. They created a computer program to search through the thousands of possible drug-disease combinations to find drugs and diseases whose gene expression patterns essentially cancelled each other out. For example, if a disease increased the activity of certain genes, the program tried to match it with one or more drugs that decreased the activity of those genes.

Many of the drug-disease matches were known, and are already in clinical use, supporting the validity of the approach. For example, the analysis correctly predicted that prednisolone could treat Crohn's disease, a condition for which it is a standard therapy.

Other matches were surprises. Butte's team chose to further investigate two such drug-disease combinations: an anti-ulcer medicine (cimetidine) that matched with lung cancer, and an anticonvulsant (topiramate) that matched with inflammatory bowel disease, which includes Crohn's disease.

To confirm the cimetidine-lung cancer link, the team tested cimetidine on human lung cancer cells in lab dishes and implanted in mice. In both cases, the drug slowed the growth of the cancer cells compared to the control group (cells or mice) that had not received cimetidine.

To test whether the anticonvulsant topiramate had an effect on inflammatory bowel diseases, the researchers administered the drug to rats that had bowel disease symptoms -- diarrhea and inflammation, ulcers and microscopic damage in the colon. The drug decreased all of these symptoms, sometimes even better than prednisolone.

The work also has more fundamental value. The scientists noticed that diseases with similar molecular processes (for example, those that affect the immune system) clustered together in the analysis. So did drugs with similar effects (for example, those that slow cell division). The researchers believe that, by studying unexpected members of these clusters, they could learn more about how certain diseases progress and how some drugs work at the molecular level.

"This work is still at an early stage, but it is a promising proof of principle for a creative, fast and affordable approach to discovering new uses for drugs we already have in our therapeutic arsenal," Long said.

This research was supported by three NIH components: the National Institute of General Medical Sciences (R01GM079719), the National Cancer Institute (R01CA138256) and the National Library of Medicine (T15LM007033).


Story Source:

The above story is based on materials provided by NIH/National Institute of General Medical Sciences. Note: Materials may be edited for content and length.


Journal References:

  1. Joel T. Dudley, Marina Sirota, Mohan Shenoy, Reetesh K. Pai, Silke Roedder, Annie P. Chiang, Alex A. Morgan, Minnie M. Sarwal, Pankaj Jay Pasricha, Atul J. Butte. Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease. Science Translational Medicine, 2011; 3 (96): 96ra76 DOI: 10.1126/scitranslmed.3002648
  2. Marina Sirota, Joel T. Dudley, Jeewon Kim, Annie P. Chiang, Alex A. Morgan, Alejandro Sweet-Cordero, Julien Sage, Atul J. Butte. Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data. Science Translational Medicine, 2011; 3 (96): 96ra77 DOI: 10.1126/scitranslmed.3001318

Cite This Page:

NIH/National Institute of General Medical Sciences. "Computational method predicts new uses for existing medicines; Match-making program uses gene expression patterns." ScienceDaily. ScienceDaily, 18 August 2011. <www.sciencedaily.com/releases/2011/08/110817142845.htm>.
NIH/National Institute of General Medical Sciences. (2011, August 18). Computational method predicts new uses for existing medicines; Match-making program uses gene expression patterns. ScienceDaily. Retrieved April 18, 2014 from www.sciencedaily.com/releases/2011/08/110817142845.htm
NIH/National Institute of General Medical Sciences. "Computational method predicts new uses for existing medicines; Match-making program uses gene expression patterns." ScienceDaily. www.sciencedaily.com/releases/2011/08/110817142845.htm (accessed April 18, 2014).

Share This



More Health & Medicine News

Friday, April 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com
Obama: 8 Million Healthcare Signups

Obama: 8 Million Healthcare Signups

AP (Apr. 17, 2014) President Barack Obama gave a briefing Thursday announcing 8 million people have signed up under the Affordable Care Act. He blasted continued Republican efforts to repeal the law. (April 17) Video provided by AP
Powered by NewsLook.com
Is Apathy A Sign Of A Shrinking Brain?

Is Apathy A Sign Of A Shrinking Brain?

Newsy (Apr. 17, 2014) A recent study links apathetic feelings to a smaller brain. Researchers say the results indicate a need for apathy screening for at-risk seniors. Video provided by Newsy
Powered by NewsLook.com
Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

More Coverage


Scientists Find New Uses for Existing Drugs by Mining Gene-Activity Data Banks

Aug. 17, 2011 Researchers have paired up medicines and maladies with help from a molecular matchmaker. When the scientists applied an "opposites attract" algorithm to publicly available databases, ... read more
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins